Literature DB >> 22374969

Multiligand specificity and wide tissue expression of GPRC6A reveals new endocrine networks.

Min Pi1, L Darryl Quarles.   

Abstract

Emerging evidence supports the hypothesis that the skeleton is an endocrine organ that regulates energy metabolism through the release of the osteoblast-derived hormone, osteocalcin (Ocn). This bone-pancreas endocrine network is controversial because important gaps remain to be filled in our knowledge of the physiological effects of Ocn in multiple organs and the complex alterations in other hormonal networks induced by Ocn administration. A key step toward understanding the integrative regulation of energy metabolism by bone is the identification of GPCR family C group 6 member A (GPRC6A) as the Ocn receptor. GPRC6A is an amino acid-sensing G protein-coupled receptor highly expressed in β-cells and is activated by recombinant Ocn in vitro and in vivo but that is widely expressed in tissues other than the pancreas and is capable of sensing multiple structurally unrelated ligands, including l-amino acids, cations, and anabolic steroids in addition to Ocn. The broad expression and multiligand specificity of GPRC6A is identifying both systemic and paracrine regulation of seemingly disparate biological processes, ranging from energy metabolism, sexual reproduction, hypothalamic-pituitary function, bone formation, and prostate cancer. Consistent with the existence of more complex endocrine networks, ablation of GPRC6A in Gprc6a(-/-) mice results in complex metabolic abnormalities, including obesity, glucose intolerance, hepatic steatosis, insulin resistance, hyperphosphatemia, osteopenia, plus several hormonal abnormalities, including decreased circulating testosterone, IGF-I, and insulin and increased estradiol, LH, GH, and leptin. Recombinant Ocn also regulates testosterone production by the testes and male fertility through a GPRC6A-dependent mechanism, and testosterone regulation of LH secretion is abnormal in Gprc6a(-/-) mice. Thus, GPRC6A, as the biologically relevant receptor for Ocn, defines not only a molecular mechanism for linking bone metabolism with metabolic regulation of β-cells and sexual reproduction but also as a receptor shared by testosterone and dietary factors, and it is also involved in multiple endocrine networks integrating the functions of pancreas, muscle, liver, fat, testes, bone, and the hypothalamic-pituitary axis with alterations in both environmental and endogenous ligands.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22374969      PMCID: PMC3339644          DOI: 10.1210/en.2011-2117

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  60 in total

1.  GPRC6A mediates the non-genomic effects of steroids.

Authors:  Min Pi; Abby L Parrill; L Darryl Quarles
Journal:  J Biol Chem       Date:  2010-10-13       Impact factor: 5.157

2.  Acute effects of testosterone infusion on the serum luteinizing hormone profile in eumenorrheic and polycystic ovary syndrome adolescents.

Authors:  María Gabriela Ropelato; María Cecilia García Rudaz; María Eugenia Escobar; Sonia Viviana Bengolea; María Luján Calcagno; Johannes D Veldhuis; Marta Barontini
Journal:  J Clin Endocrinol Metab       Date:  2009-06-30       Impact factor: 5.958

3.  Prospective studies of dairy product and calcium intakes and prostate cancer risk: a meta-analysis.

Authors:  Xiang Gao; Michael P LaValley; Katherine L Tucker
Journal:  J Natl Cancer Inst       Date:  2005-12-07       Impact factor: 13.506

4.  Identification of a novel extracellular cation-sensing G-protein-coupled receptor.

Authors:  Min Pi; Pieter Faber; George Ekema; P David Jackson; Anthony Ting; Nancy Wang; Michelle Fontilla-Poole; Robert W Mays; Kurt R Brunden; John J Harrington; L Darryl Quarles
Journal:  J Biol Chem       Date:  2005-09-30       Impact factor: 5.157

Review 5.  Structure, pharmacology and therapeutic prospects of family C G-protein coupled receptors.

Authors:  Hans Bräuner-Osborne; Petrine Wellendorph; Anders A Jensen
Journal:  Curr Drug Targets       Date:  2007-01       Impact factor: 3.465

6.  Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trial.

Authors:  Alan R Kristal; Kathryn B Arnold; Marian L Neuhouser; Phyllis Goodman; Elizabeth A Platz; Demetrius Albanes; Ian M Thompson
Journal:  Am J Epidemiol       Date:  2010-08-06       Impact factor: 4.897

7.  Metabolomic analysis of the response of growing pigs to dietary L-arginine supplementation.

Authors:  Qinghua He; Xiangfeng Kong; Guoyao Wu; Pingping Ren; Huiru Tang; Fuhua Hao; Ruilin Huang; Tiejun Li; Bie Tan; Peng Li; Zhiru Tang; Yulong Yin; Yongning Wu
Journal:  Amino Acids       Date:  2008-11-07       Impact factor: 3.520

8.  Endocrine regulation of energy metabolism by the skeleton.

Authors:  Na Kyung Lee; Hideaki Sowa; Eiichi Hinoi; Mathieu Ferron; Jong Deok Ahn; Cyrille Confavreux; Romain Dacquin; Patrick J Mee; Marc D McKee; Dae Young Jung; Zhiyou Zhang; Jason K Kim; Franck Mauvais-Jarvis; Patricia Ducy; Gerard Karsenty
Journal:  Cell       Date:  2007-08-10       Impact factor: 41.582

9.  Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels.

Authors:  Abbas Dehghan; Josée Dupuis; Maja Barbalic; Joshua C Bis; Gudny Eiriksdottir; Chen Lu; Niina Pellikka; Henri Wallaschofski; Johannes Kettunen; Peter Henneman; Jens Baumert; David P Strachan; Christian Fuchsberger; Veronique Vitart; James F Wilson; Guillaume Paré; Silvia Naitza; Megan E Rudock; Ida Surakka; Eco J C de Geus; Behrooz Z Alizadeh; Jack Guralnik; Alan Shuldiner; Toshiko Tanaka; Robert Y L Zee; Renate B Schnabel; Vijay Nambi; Maryam Kavousi; Samuli Ripatti; Matthias Nauck; Nicholas L Smith; Albert V Smith; Jouko Sundvall; Paul Scheet; Yongmei Liu; Aimo Ruokonen; Lynda M Rose; Martin G Larson; Ron C Hoogeveen; Nelson B Freimer; Alexander Teumer; Russell P Tracy; Lenore J Launer; Julie E Buring; Jennifer F Yamamoto; Aaron R Folsom; Eric J G Sijbrands; James Pankow; Paul Elliott; John F Keaney; Wei Sun; Antti-Pekka Sarin; João D Fontes; Sunita Badola; Brad C Astor; Albert Hofman; Anneli Pouta; Karl Werdan; Karin H Greiser; Oliver Kuss; Henriette E Meyer zu Schwabedissen; Joachim Thiery; Yalda Jamshidi; Ilja M Nolte; Nicole Soranzo; Timothy D Spector; Henry Völzke; Alexander N Parker; Thor Aspelund; David Bates; Lauren Young; Kim Tsui; David S Siscovick; Xiuqing Guo; Jerome I Rotter; Manuela Uda; David Schlessinger; Igor Rudan; Andrew A Hicks; Brenda W Penninx; Barbara Thorand; Christian Gieger; Joe Coresh; Gonneke Willemsen; Tamara B Harris; Andre G Uitterlinden; Marjo-Riitta Järvelin; Kenneth Rice; Dörte Radke; Veikko Salomaa; Ko Willems van Dijk; Eric Boerwinkle; Ramachandran S Vasan; Luigi Ferrucci; Quince D Gibson; Stefania Bandinelli; Harold Snieder; Dorret I Boomsma; Xiangjun Xiao; Harry Campbell; Caroline Hayward; Peter P Pramstaller; Cornelia M van Duijn; Leena Peltonen; Bruce M Psaty; Vilmundur Gudnason; Paul M Ridker; Georg Homuth; Wolfgang Koenig; Christie M Ballantyne; Jacqueline C M Witteman; Emelia J Benjamin; Markus Perola; Daniel I Chasman
Journal:  Circulation       Date:  2011-02-07       Impact factor: 29.690

Review 10.  Amino acids and diabetes: implications for endocrine, metabolic and immune function.

Authors:  Philip Newsholme; Fernando Abdulkader; Eduardo Rebelato; Talita Romanatto; Carlos Hermano J Pinheiro; Kaio Fernando Vitzel; Erica Portioli Silva; Roberto B Bazotte; Joaquim Procopio; Rui Curi; Renata Gorjao; Tania Cristina Pithon-Curi
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01
View more
  38 in total

Review 1.  Regulation of Energy Metabolism by Bone-Derived Hormones.

Authors:  Paula Mera; Mathieu Ferron; Ioanna Mosialou
Journal:  Cold Spring Harb Perspect Med       Date:  2018-06-01       Impact factor: 6.915

Review 2.  An overview of osteocalcin progress.

Authors:  Jinqiao Li; Hongyu Zhang; Chao Yang; Yinghui Li; Zhongquan Dai
Journal:  J Bone Miner Metab       Date:  2016-01-08       Impact factor: 2.626

3.  RGS12 Is a Novel Tumor-Suppressor Gene in African American Prostate Cancer That Represses AKT and MNX1 Expression.

Authors:  Yongquan Wang; Jianghua Wang; Li Zhang; Omer Faruk Karatas; Longjiang Shao; Yiqun Zhang; Patricia Castro; Chad J Creighton; Michael Ittmann
Journal:  Cancer Res       Date:  2017-06-13       Impact factor: 12.701

Review 4.  Bone, brain & beyond.

Authors:  Alexandre Chamouni; Christiane Schreiweis; Franck Oury
Journal:  Rev Endocr Metab Disord       Date:  2015-06       Impact factor: 6.514

5.  Growth Control: A Saga of Cell Walls, ROS, and Peptide Receptors.

Authors:  Sebastian Wolf; Herman Höfte
Journal:  Plant Cell       Date:  2014-05-07       Impact factor: 11.277

6.  Searching for additional endocrine functions of the skeleton: genetic approaches and implications for therapeutics.

Authors:  Jianwen Wei; Stephen Flaherty; Gerard Karsenty
Journal:  Expert Rev Endocrinol Metab       Date:  2015-06-16

7.  Genetic Variations in the Human G Protein-coupled Receptor Class C, Group 6, Member A (GPRC6A) Control Cell Surface Expression and Function.

Authors:  Stine Jørgensen; Christian Theil Have; Christina Rye Underwood; Lars Dan Johansen; Petrine Wellendorph; Anette Prior Gjesing; Christinna V Jørgensen; Shi Quan; Gao Rui; Asuka Inoue; Allan Linneberg; Niels Grarup; Wang Jun; Oluf Pedersen; Torben Hansen; Hans Bräuner-Osborne
Journal:  J Biol Chem       Date:  2016-12-16       Impact factor: 5.157

8.  GPRC6A mediates the effects of L-arginine on insulin secretion in mouse pancreatic islets.

Authors:  Min Pi; Yunpeng Wu; Nataliya I Lenchik; Ivan Gerling; L Darryl Quarles
Journal:  Endocrinology       Date:  2012-08-07       Impact factor: 4.736

9.  The effects of muscle contraction and recombinant osteocalcin on insulin sensitivity ex vivo.

Authors:  I Levinger; X Lin; X Zhang; T C Brennan-Speranza; B Volpato; A Hayes; G Jerums; E Seeman; G McConell
Journal:  Osteoporos Int       Date:  2015-08-11       Impact factor: 4.507

Review 10.  Orphan GPCRs and neuromodulation.

Authors:  Olivier Civelli
Journal:  Neuron       Date:  2012-10-04       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.